Autopsy report · NCT01811693

Field Administration of Stroke Therapy-Blood Pressure Lowering

“The funding period for the study has ended.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 8 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 6 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Intracerebral Hemorrhage; Ischemic Stroke

Interventions

Glycerly Trinitrate; Glycerly Trinitrate; Glycerly Trinitrate

Participants

4

Sites

2

Countries

United States

Trials that died the same way

• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (94% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (88% match in meaning)
• Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
  “The study terminated due to funding ending.” (87% match in meaning)
• Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
  “study funding period ended March 2022” (84% match in meaning)
• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
  “The study was closed due to the end of funding.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.